Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Shanghai Jiaotong University School of Medicine | Shanghai Changzheng Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study on Acetyl-L-Carnitine
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 06, 2012
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Shanghai Jiaotong University School of Medicine | Shanghai Changzheng Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Vitrolife
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 23, 2016
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Vitrolife
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 04, 2016
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable